Pages that link to "Q24305365"
Jump to navigation
Jump to search
The following pages link to Retracted: Epithelial Membrane Protein-2 Promotes Endometrial Tumor Formation through Activation of FAK and Src (Q24305365):
Displayed 31 items.
- protein tyrosine kinase 2 (Q2744706) (← links)
- Epithelial membrane protein 2 (Q21130759) (← links)
- EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF (Q24310236) (← links)
- The APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesis (Q28255263) (← links)
- Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer (Q33559314) (← links)
- Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma (Q33619401) (← links)
- Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer. (Q33668653) (← links)
- The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma (Q35832332) (← links)
- Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments (Q36557471) (← links)
- FAK-Src signalling is important to renal collecting duct morphogenesis: discovery using a hierarchical screening technique (Q36764314) (← links)
- A human XPC protein interactome--a resource (Q37535414) (← links)
- Review of the GAS3 Family of Proteins and their Relevance to Cancer (Q37716267) (← links)
- Epithelial membrane protein 2: Molecular interactions and clinical implications (Q38655688) (← links)
- EMP2 re-expression inhibits growth and enhances radiosensitivity in nasopharyngeal carcinoma (Q38710251) (← links)
- EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer (Q39241308) (← links)
- Epithelial Membrane Protein 2 and β1 integrin signaling regulate APC-mediated processes (Q42502292) (← links)
- EMP2 is a novel therapeutic target for endometrial cancer stem cells (Q46644180) (← links)
- Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. (Q47830458) (← links)
- Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency (Q48125821) (← links)
- Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model (Q60922868) (← links)
- Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy (Q89591425) (← links)
- Genetic Deletion of Emp2 Does Not Cause Proteinuric Kidney Disease in Mice (Q90053787) (← links)
- Epithelial membrane protein 2 governs transepithelial migration of neutrophils into the airspace (Q90255301) (← links)
- The Pivotal Roles of the Epithelial Membrane Protein Family in Cancer Invasiveness and Metastasis (Q90945187) (← links)
- Loss of Emp2 compromises cardiogenic differentiation in mouse embryonic stem cells (Q91655305) (← links)
- miRNA Regulation of the Hyperproliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes (Q91783613) (← links)
- Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies (Q91963232) (← links)
- Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors (Q98781774) (← links)
- Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single-cell transcriptome analysis (Q104617791) (← links)
- Retraction: Epithelial Membrane Protein-2 Promotes Endometrial Tumor Formation through Activation of FAK and Src (Q114749070) (← links)
- Wikidata:Database reports/Constraint violations/P5824 (← links | edit)